| William John Crabb, MD | |
|
315 Martin Luther King Jr Way, Tacoma, WA 98405-4234 | |
| (253) 403-1050 | |
| Not Available |
| Full Name | William John Crabb |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 315 Martin Luther King Jr Way, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770684961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD00024134 (Washington) | Primary |
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Several recent studies have suggested that common gene variations may be responsible for much of the elevated risk of kidney disease in African Americans.
Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a group of 10 patients and is expected to become an essential tool in situations where other, catheter-free hemodialysis approaches are not possible.
Labopharm Inc. today reported its financial results for the first quarter 2010.
› Verified 7 days ago
| Entity Name | Tacoma Emergency Care Physicians Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770823791 PECOS PAC ID: 5294971800 Enrollment ID: O20130425000636 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Several recent studies have suggested that common gene variations may be responsible for much of the elevated risk of kidney disease in African Americans.
Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a group of 10 patients and is expected to become an essential tool in situations where other, catheter-free hemodialysis approaches are not possible.
Labopharm Inc. today reported its financial results for the first quarter 2010.
› Verified 7 days ago
| Entity Name | Western Washington Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801352505 PECOS PAC ID: 0749514735 Enrollment ID: O20190625002379 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Several recent studies have suggested that common gene variations may be responsible for much of the elevated risk of kidney disease in African Americans.
Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a group of 10 patients and is expected to become an essential tool in situations where other, catheter-free hemodialysis approaches are not possible.
Labopharm Inc. today reported its financial results for the first quarter 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William John Crabb, MD 315 Martin Luther King Jr Way, Tacoma, WA 98405-4234 Ph: (253) 403-1050 | William John Crabb, MD 315 Martin Luther King Jr Way, Tacoma, WA 98405-4234 Ph: (253) 403-1050 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
Several recent studies have suggested that common gene variations may be responsible for much of the elevated risk of kidney disease in African Americans.
Researchers at Okayama University report in The Journal of Vascular Access a supporting device for accurately placing hemodialysis catheters on kidney patients. The device was successfully used on a group of 10 patients and is expected to become an essential tool in situations where other, catheter-free hemodialysis approaches are not possible.
Labopharm Inc. today reported its financial results for the first quarter 2010.
› Verified 7 days ago
Dr. Justin Cha-cheng Ng, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-2050 | |
Robert F Wachtel, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
Dr. Nathan Kinneer Friedline, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 9040 Jackson Ave, Tacoma, WA 98433 Phone: 850-885-2273 | |
Barbara Sherry Mezger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-596-3400 Fax: 253-596-3301 | |
Dr. Peter Stull, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Madigan Army Medical Center 9040 Jackson Ave, Tacoma, WA 98431 Phone: 253-968-1250 Fax: 253-968-2550 | |
Kevin E Callahan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Martin Luther King Jr Way, Tacoma, WA 98405 Phone: 253-403-1000 | |
June A Burn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 14815 Pacific Ave S, Tacoma, WA 98444 Phone: 253-697-8660 |